These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 29739801

  • 1. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
    Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ, Lee LV, Goldberg AC, Roger VL, Robinson J, Peterson ED.
    J Am Heart Assoc; 2018 May 08; 7(10):. PubMed ID: 29739801
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
    Laleman N, Henrard S, van den Akker M, Goderis G, Buntinx F, Van Pottelbergh G, Vaes B.
    BMC Cardiovasc Disord; 2018 Nov 06; 18(1):209. PubMed ID: 30400778
    [Abstract] [Full Text] [Related]

  • 4. Lipid Testing and Statin Dosing After Acute Myocardial Infarction.
    Wang WT, Hellkamp A, Doll JA, Thomas L, Navar AM, Fonarow GC, Julien HM, Peterson ED, Wang TY.
    J Am Heart Assoc; 2018 Jan 25; 7(3):. PubMed ID: 29371200
    [Abstract] [Full Text] [Related]

  • 5. Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry.
    Navar AM, Wang TY, Li S, Robinson JG, Goldberg AC, Virani S, Roger VL, Wilson PWF, Elassal J, Lee LV, Peterson ED.
    Am Heart J; 2017 Nov 25; 193():84-92. PubMed ID: 29129260
    [Abstract] [Full Text] [Related]

  • 6. Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry.
    Lowenstern AM, Li S, Navar AM, Roger VL, Robinson JG, Goldberg AC, Virani SS, Lee LV, Wilson PWF, Louie MJ, Peterson ED, Wang TY.
    J Am Heart Assoc; 2018 Sep 18; 7(18):e009251. PubMed ID: 30371214
    [Abstract] [Full Text] [Related]

  • 7. Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.
    Nanna MG, Navar AM, Zakroysky P, Xiang Q, Goldberg AC, Robinson J, Roger VL, Virani SS, Wilson PWF, Elassal J, Lee LV, Wang TY, Peterson ED.
    JAMA Cardiol; 2018 Aug 01; 3(8):739-748. PubMed ID: 29898219
    [Abstract] [Full Text] [Related]

  • 8. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
    Xian Y, Navar AM, Li S, Li Z, Robinson J, Virani SS, Louie MJ, Koren A, Goldberg A, Roger VL, Wilson PWF, Peterson ED, Wang TY.
    J Am Heart Assoc; 2019 Oct 01; 8(19):e013229. PubMed ID: 31554462
    [Abstract] [Full Text] [Related]

  • 9. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T, Zhou S, Anzalone D, Kern DM, Tunceli O, Cziraky MJ, Willey VJ.
    J Am Heart Assoc; 2017 May 04; 6(5):. PubMed ID: 28473405
    [Abstract] [Full Text] [Related]

  • 10. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E, Rittner SS, Carroll JE, Crawford PM, Dant L, Laws R, Leo MC, Puro J, Persell SD.
    J Am Heart Assoc; 2017 Jul 03; 6(7):. PubMed ID: 28673901
    [Abstract] [Full Text] [Related]

  • 11. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW, de Vries JK, Mulder DJ, Kamphuisen PW.
    Eur J Prev Cardiol; 2017 Jul 03; 24(10):1064-1070. PubMed ID: 28429651
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
    Bai JW, Boulet G, Halpern EM, Lovblom LE, Eldelekli D, Keenan HA, Brent M, Paul N, Bril V, Cherney DZ, Weisman A, Perkins BA.
    Cardiovasc Diabetol; 2016 Jan 25; 15():14. PubMed ID: 26809442
    [Abstract] [Full Text] [Related]

  • 13. Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry.
    Nanna MG, Navar AM, Wang TY, Li S, Virani SS, Li Z, Robinson JG, Roger VL, Wilson PWF, Goldberg AC, Koren A, Louie MJ, Peterson ED.
    Am Heart J; 2019 Aug 25; 214():113-124. PubMed ID: 31202098
    [Abstract] [Full Text] [Related]

  • 14. Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia.
    O'Donnell TFX, Deery SE, Darling JD, Shean KE, Mittleman MA, Yee GN, Dernbach MR, Schermerhorn ML.
    J Vasc Surg; 2017 Aug 25; 66(2):572-578. PubMed ID: 28506476
    [Abstract] [Full Text] [Related]

  • 15. Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry).
    Lowenstern A, Navar AM, Li S, Virani SS, Goldberg AC, Louie MJ, Lee LV, Peterson ED, Wang TY.
    Am J Cardiol; 2019 Apr 01; 123(7):1011-1018. PubMed ID: 30660354
    [Abstract] [Full Text] [Related]

  • 16. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA, Bushnik T, Manuel DG, Anderson TJ.
    J Am Heart Assoc; 2015 Jul 14; 4(7):. PubMed ID: 26175357
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.
    Navar AM, Peterson ED, Li S, Robinson JG, Roger VL, Goldberg AC, Virani S, Wilson PWF, Nanna MG, Lee LV, Elassal J, Wang TY.
    Circ Cardiovasc Qual Outcomes; 2018 Mar 14; 11(3):e004249. PubMed ID: 29545393
    [No Abstract] [Full Text] [Related]

  • 18. Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.
    Stam-Slob MC, Visseren FL, Wouter Jukema J, van der Graaf Y, Poulter NR, Gupta A, Sattar N, Macfarlane PW, Kearney PM, de Craen AJ, Trompet S.
    Clin Res Cardiol; 2017 Jan 14; 106(1):58-68. PubMed ID: 27554244
    [Abstract] [Full Text] [Related]

  • 19. Inception and deprescribing of statins in people aged over 80 years: cohort study.
    Gulliford M, Ravindrarajah R, Hamada S, Jackson S, Charlton J.
    Age Ageing; 2017 Nov 01; 46(6):1001-1005. PubMed ID: 29088364
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcomes with high-intensity statins according to atherothrombotic risk stratification after acute myocardial infarction: The FAST-MI registries.
    Desjobert E, Tea V, Schiele F, Ferrières J, Simon T, Danchin N, Puymirat E, FAST-MI investigators.
    Arch Cardiovasc Dis; 2021 Feb 01; 114(2):88-95. PubMed ID: 33011156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.